NASDAQ:ADMP
$0.196
(
-0.0510%
)
Friday, 27th Jan 2023
Adamis Pharmaceuticals Corporation Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.141 | $0.230 | Friday, 27th Jan 2023 ADMP stock ended at $0.196. This is 0.051% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 7.26% from a day low at $0.190 to a day high of $0.204. |
| 90 days | $0.127 | $0.233 | |
| 52 weeks | $0.120 | $0.730 |
Historical Adamis Pharmaceuticals Corporation prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.194 | $0.204 | $0.190 | $0.196 | 336 599 |
| 2023-01-26 | $0.198 | $0.204 | $0.190 | $0.196 | 403 847 |
| 2023-01-25 | $0.199 | $0.200 | $0.190 | $0.198 | 581 209 |
| 2023-01-24 | $0.206 | $0.206 | $0.194 | $0.199 | 238 181 |
| 2023-01-23 | $0.194 | $0.210 | $0.194 | $0.200 | 756 680 |
| 2023-01-20 | $0.191 | $0.199 | $0.189 | $0.194 | 476 214 |
| 2023-01-19 | $0.200 | $0.200 | $0.185 | $0.188 | 506 415 |
| 2023-01-18 | $0.225 | $0.225 | $0.202 | $0.204 | 437 109 |
| 2023-01-17 | $0.220 | $0.230 | $0.210 | $0.218 | 523 048 |
| 2023-01-13 | $0.210 | $0.220 | $0.208 | $0.218 | 445 581 |
| 2023-01-12 | $0.230 | $0.230 | $0.210 | $0.220 | 312 800 |
| 2023-01-11 | $0.210 | $0.220 | $0.210 | $0.220 | 370 500 |
| 2023-01-10 | $0.210 | $0.220 | $0.200 | $0.210 | 999 800 |
| 2023-01-09 | $0.200 | $0.210 | $0.200 | $0.200 | 795 600 |
| 2023-01-06 | $0.170 | $0.200 | $0.170 | $0.200 | 913 300 |
| 2023-01-05 | $0.169 | $0.171 | $0.166 | $0.169 | 155 647 |
| 2023-01-04 | $0.170 | $0.171 | $0.158 | $0.169 | 474 771 |
| 2023-01-03 | $0.165 | $0.175 | $0.160 | $0.165 | 669 931 |
| 2022-12-30 | $0.152 | $0.175 | $0.150 | $0.169 | 1 161 331 |
| 2022-12-29 | $0.143 | $0.159 | $0.141 | $0.152 | 589 592 |
| 2022-12-28 | $0.152 | $0.164 | $0.150 | $0.151 | 499 301 |
| 2022-12-27 | $0.136 | $0.169 | $0.136 | $0.154 | 420 752 |
| 2022-12-23 | $0.152 | $0.167 | $0.141 | $0.156 | 698 796 |
| 2022-12-22 | $0.152 | $0.171 | $0.152 | $0.160 | 560 339 |
| 2022-12-21 | $0.132 | $0.170 | $0.130 | $0.160 | 860 642 |
| 2022-12-20 | $0.153 | $0.170 | $0.143 | $0.144 | 1 274 195 |
| 2022-12-19 | $0.151 | $0.168 | $0.150 | $0.156 | 736 045 |
| 2022-12-16 | $0.165 | $0.180 | $0.150 | $0.150 | 984 656 |
| 2022-12-15 | $0.156 | $0.182 | $0.156 | $0.170 | 734 729 |
| 2022-12-14 | $0.170 | $0.177 | $0.164 | $0.164 | 355 760 |
| 2022-12-13 | $0.183 | $0.189 | $0.154 | $0.171 | 697 173 |
| 2022-12-12 | $0.190 | $0.190 | $0.180 | $0.183 | 569 269 |
| 2022-12-09 | $0.185 | $0.190 | $0.183 | $0.184 | 272 469 |
| 2022-12-08 | $0.185 | $0.200 | $0.181 | $0.190 | 623 274 |
| 2022-12-07 | $0.187 | $0.190 | $0.183 | $0.187 | 298 518 |
| 2022-12-06 | $0.191 | $0.208 | $0.180 | $0.185 | 492 298 |
| 2022-12-05 | $0.194 | $0.209 | $0.191 | $0.193 | 502 622 |
| 2022-12-02 | $0.200 | $0.205 | $0.191 | $0.200 | 299 417 |
| 2022-12-01 | $0.197 | $0.210 | $0.194 | $0.201 | 311 886 |
| 2022-11-30 | $0.207 | $0.207 | $0.191 | $0.200 | 426 592 |
| 2022-11-29 | $0.193 | $0.220 | $0.193 | $0.205 | 749 744 |
| 2022-11-28 | $0.190 | $0.200 | $0.185 | $0.193 | 474 579 |
| 2022-11-25 | $0.188 | $0.190 | $0.185 | $0.186 | 249 325 |
| 2022-11-23 | $0.200 | $0.200 | $0.187 | $0.191 | 549 276 |
| 2022-11-22 | $0.200 | $0.201 | $0.190 | $0.197 | 496 517 |
| 2022-11-21 | $0.210 | $0.210 | $0.185 | $0.197 | 301 385 |
| 2022-11-18 | $0.210 | $0.210 | $0.200 | $0.208 | 249 548 |
| 2022-11-17 | $0.193 | $0.219 | $0.181 | $0.208 | 711 580 |
| 2022-11-16 | $0.214 | $0.214 | $0.198 | $0.200 | 961 596 |
| 2022-11-15 | $0.180 | $0.233 | $0.180 | $0.221 | 2 126 867 |
About Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products for the ... ADMP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
